Subsequently, a committee was created in 1993 chaired by Folke Sjöqvist[1] with the remit to prepare the first congress of EACPT, held in Paris in 1995.

[2] At that congress the founding EACPT Council elected an Executive Committee with Sjöqvist as chairman, Michael Orme (United Kingdom) as Honorary Secretary, Jochen Kuhlmann (Germany) as Treasurer, and Giampaolo Velo (Italy) as Vice-Chairman, with 26 European countries as members through their home country clinical pharmacology society or section.

[7] Source:[10] Congresses[11] are open to delegates from Europe and anywhere in the world, including health professionals, researchers, biotechnology and pharmaceutical industry professionals, regulators, policy makers, ethicists and others interested in drug discovery, and in clinical, cost-effectiveness and safety of medicines and related biomarkers.

The EACPT is led by an Executive Committee[22] formed from a council of delegates from affiliated national societies[23] for clinical pharmacology and therapeutics.

The EACPT also has key Working Groups for Research, Ethics and Regulatory Matters, Education and Young Pharmacologists.